Azacitidine – September 2022

• Brand names:
  • Onureg®
• Pharmaceutical Company:
  • Celgene Pty Limited
• Condition/Indication: Acute myeloid leukaemia
• Meeting Date: September 2022
• Public Summary Document (PSD) July 2022 September 2022 PBAC Meeting – (PDF 1.2MB)
• Public Summary Document (PSD) July 2022 September 2022 PBAC Meeting – (Word 822KB)

Related Public Summary Documents

• Azacitidine – July 2022